The patient's clinical presentation suggested a UTI accompanied by an anion gap metabolic acidosis, possibly secondary to lactic acidosis stemming from UTI-related sepsis or euDKA secondary to empagliflozin, an SGLT2 inhibitor. The gene discussed is SLC5A2; the disease is bacterial urinary tract infection.